GSK plc filed a Form 6-K with the U.S. Securities and Exchange Commission on October 26, 2026, disclosing a transaction notification for Maya Martinez-Davis, President, US, involving the acquisition of notional American Depositary Shares within her GSK Executive Supplemental Savings Plan account.

Key Highlights

  • Reporting person: Maya Martinez-Davis, identified as President, US at GSK plc.
  • Transaction type: Acquisition of notional ADS within Ms. Martinez-Davis's GSK Executive Supplemental Savings Plan account.
  • Security: American Depositary Shares (ADS), ISIN US37733W2044.
  • Price and volume: 9.324 notional ADS acquired at $51.2100 per ADS.
  • Transaction date: October 22, 2026, on the New York Stock Exchange (XNYS).
  • Filing classification: Initial notification, reported for the month of October 2026.

GSK Transaction Notification: Martinez-Davis Executive Savings Plan ADS Acquisition

According to the Form 6-K filed by GSK plc (NYSE:GSK) on October 26, 2026, Maya Martinez-Davis, who holds the position of President, US, acquired notional American Depositary Shares within her GSK Executive Supplemental Savings Plan account. The filing identifies this as an initial notification and covers a single transaction conducted on October 22, 2026.

The filing discloses that the transaction involved 9.324 notional ADS at a price of $51.2100 per share. The instrument is identified by ISIN US37733W2044, and the place of the transaction is listed as the New York Stock Exchange (XNYS). Because the filing describes the shares as "notional ADS" held within an Executive Supplemental Savings Plan account, the transaction reflects a plan-based acquisition rather than an open-market purchase of ordinary shares.

GSK plc describes itself in the filing as "a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together." The company is registered in England and Wales under number 3888792, with its registered office at 79 New Oxford Street, London. The 6-K was signed on behalf of GSK plc by Victoria Whyte, Authorised Signatory, and submitted under Commission File Number 001-15170.

What Was Disclosed

GSK plc disclosed a transaction notification showing that Maya Martinez-Davis, President, US, acquired 9.324 notional ADS at $51.2100 each on October 22, 2026, within her GSK Executive Supplemental Savings Plan account, as reported in a Form 6-K for the month of October 2026.